Quick search:
Content Search
Result Content Research
Result Content Research
1 BNT162b2 and ChAdOx1 nCoV-19 Vaccine Effectiveness against Death from the Delta Variant | NEJM
2 Covid-19 Vaccination during Pregnancy and First-Trimester Miscarriage | NEJM
3 Uncomfortable Truths — What Covid-19 Has Revealed about Chronic-Disease Care in America
4 Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19 | NEJM
5 Differential Kinetics of Immune Responses Elicited by Covid-19 Vaccines | NEJM
6 Closing the Gender Pay Gap in Medicine | NEJM
7 The Billboard | NEJM
8 AQP1 Variant and Peritoneal Dialysis
9 Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults | NEJM
10 Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar
11 Myocarditis after Covid-19 Vaccination in a Large Health Care Organization | NEJM
12 Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
13 Point-of-Care Ultrasonography
14 Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months
15 REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19
16 Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
17 Is It Finally Time for a Medicare Dental Benefit? | NEJM
18 Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine | NEJM
19 Intracardiac Cement Embolism | NEJM
20 Convalescent Plasma for Outpatients with Covid-19
21 Covid-19 Breakthrough Infections in Vaccinated Health Care Workers
22 SARS-CoV-2 Infection among Nursing Home Residents
23 A Good Death? | NEJM
24 Intervention Timing for Infected Necrotizing Pancreatitis | NEJM
25 Obesity-Associated GNAS Mutations and the Melanocortin Pathway | NEJM
26 Methods of Public Health Research — Strengthening Causal Inference from Observational Data
27 SARS-CoV-2 Human Challenge Studies
28 Blood Donation by Gay and Bisexual Men — The Need for a Policy Update
29 Placement of a Double-Lumen Endotracheal Tube
30 Hard to Swallow
31 NEJM — Fundamentals of Public Health
32 COVID SCIENCE-COVID-19 vaccines not linked to pregnancy loss; mixing vaccines may confer greater protection
33 2 Hospitalizations, 10 New Cases Reported Today – Redheaded Blackbelt
34 Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19 | NEJM
35 Call for Emergency Action to Limit Global Temperature Increases, Restore Biodiversity, and Protect Health | NEJM
36 Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
37 Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting | NEJM
38 Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines | NEJM
39 Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce
40 Effectiveness of mRNA Covid-19 Vaccine among US Health Care Personnel
41 Effect of Salt Substitution on Cardiovascular Events and Death
42 Early Convalescent Plasma for High-Risk Outpatients with Covid-19 | NEJM
43 Mask Wars | NEJM
44 SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3 | NEJM
45 Evaluation of mRNA-1273 SARS-CoV-2 Vaccine in Adolescents | NEJM
46 Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons | NEJM
47 MRNA Covid-19 Vaccines in Pregnant Women | NEJM
48 Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel | NEJM
49 Efficacy of Wolbachia-Infected Mosquito Deployments for the Control of Dengue | NEJM
50 Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis
51 Confronting Our Next National Health Disaster — Long-Haul Covid | NEJM
52 Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19 | NEJM
53 Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents | NEJM
54 Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension | NEJM
55 BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
56 Race in Medicine — Genetic Variation, Social Categories, and Paths to Health Equity | NEJM
57 Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination | NEJM
58 Effect of Vaccination on Transmission of SARS-CoV-2
59 SARS-CoV-2 Variants in Patients with Immunosuppression | NEJM
60 Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients | NEJM
61 Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia | NEJM
62 Durable Humoral and Cellular Immune Responses 8 Months after Ad26.COV2.S Vaccination
63 CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis | NEJM
64 Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine | NEJM
65 Long-Term Complications in Youth-Onset Type 2 Diabetes | NEJM
66 Household Transmission of SARS-CoV-2 from Children and Adolescents | NEJM
67 Empagliflozin in Heart Failure with a Preserved Ejection Fraction | NEJM
68 Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
69 Atreca Enters into Licensing Agreement with Bill & Melinda Gates Medical Research Institute ...
70 Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19 | NEJM
71 Early Evidence of the Effect of SARS-CoV-2 Vaccine at One Medical Center
72 Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
73 Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
74 SARS-CoV-2 Variants and Vaccines | NEJM
75 Covid-19 Vaccine Resources
76 Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 | NEJM
77 On Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons | NEJM
78 Receipt of mRNA Covid-19 Vaccines and Risk of Spontaneous Abortion | NEJM
79 Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest | NEJM
80 Treatment of Older Adults with Cancer — Addressing Gaps in Evidence
81 Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19 | NEJM
82 The Covid-19 Infodemic — Applying the Epidemiologic Model to Counter Misinformation
83 Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination | NEJM
84 Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
85 When Low Tech Wins
86 Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention
87 The Complementarity of Public Health and Medicine — Achieving “the Highest Attainable Standard of Health” | NEJM
88 Effect of Vaccination on Household Transmission of SARS-CoV-2 in England
89 Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
90 Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock | NEJM
91 The Pathophysiology of Racial Disparities
92 Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant | NEJM
93 MRI-Targeted or Standard Biopsy in Prostate Cancer Screening
94 Genomewide Association Study of Severe Covid-19 with Respiratory Failure | NEJM
95 Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
96 Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
97 Protecting Olympic Participants from Covid-19 — The Urgent Need for a Risk-Management Approach | NEJM
98 New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications | NEJM
99 Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM
100 Decline in Pathogenic Antibodies over Time in VITT | NEJM